Billie Tack
Women's Health · Clinton, IANPI 1003866674
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $589 of the $689 with a category attached, or 85.5%. 10 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 40.4% of the total. Reporting peaked in 2021 at $358 and has fallen 74.8% since, to $90 in 2024.
Across 22 payments — averaging $31.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$279
- Astellas Pharma US Inc$209
- Agile Therapeutics, Inc.$49
- AbbVie$43
- Exeltis, USA Inc.$31
- Exact Sciences$22
- plus $56 from 4 others
What the payments were for
- Food & beverage$58985%
- Education$10015%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 2 | $279 |
| Astellas Pharma US Inc | 7 | $209 |
| Agile Therapeutics, Inc. | 3 | $49 |
| AbbVie | 3 | $43 |
| Exeltis, USA Inc. | 2 | $31 |
| Exact Sciences | 1 | $22 |
| BD | 1 | $16 |
| Myovant Sciences Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$689 in reported general payments places this provider in the 75th percentile of 58 women's health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $2,155 |
| ValacyclovirValacyclovir Hcl | 12 | $434 |
| Norethindrone | 12 | $352 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $41 |
| Alprazolam | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other women's health in Clinton
- Janice ClarkClinton$111
- Katie KreamerClinton$13
- Darci LewisDes Moines$17K
- Tami SheldonDavenport$8K
- Susan SchaferDavenport$4K
- Stacy PohlmanCoralville$4K
- Marissa HuettmanBettendorf$3K
- P NeilsonDavenport$3K
- Amy StegerCedar Rapids$2K
- Brandy MitchellIowa City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.